Search hospitals > Ohio > Independence
Cleveland Clinic Cancer Center Independence
Claim this profileIndependence, Ohio 44131
Global Leader in Breast Cancer
Global Leader in Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Prostate Cancer
141 reported clinical trials
15 medical researchers
Summary
Cleveland Clinic Cancer Center Independence is a medical facility located in Independence, Ohio. This center is recognized for care of Breast Cancer, Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Prostate Cancer and other specialties. Cleveland Clinic Cancer Center Independence is involved with conducting 141 clinical trials across 186 conditions. There are 15 research doctors associated with this hospital, such as Nathan A. Pennell, Aaron Gerds, MD, MS, Joel N. Saltzman, and Gregory M. M. Videtic.Area of expertise
1Breast Cancer
Global LeaderStage IV
HER2 negative
ER positive
2Cancer
Global LeaderStage III
Stage IV
Stage II
Top PIs
Nathan A. PennellCleveland Clinic Foundation2 years of reported clinical research
Expert in Non-Small Cell Lung Cancer
Expert in Lung Cancer
16 reported clinical trials
25 drugs studied
Aaron Gerds, MD, MSCleveland Clinic Foundation5 years of reported clinical research
Studies Myelofibrosis
Studies Primary Myelofibrosis
11 reported clinical trials
17 drugs studied
Joel N. SaltzmanUHHS-Chagrin Highlands Medical Center4 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
7 reported clinical trials
20 drugs studied
Gregory M. M. VideticCleveland Clinic Foundation4 years of reported clinical research
Studies Lung Cancer
Studies Small Cell Lung Cancer
5 reported clinical trials
15 drugs studied
Clinical Trials running at Cleveland Clinic Cancer Center Independence
Breast Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Diffuse Large B-Cell Lymphoma
Squamous Cell Carcinoma
Colon Cancer
Anal Cancer
Cancer
Colorectal Cancer
Lymphoma
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Chemotherapy Reduction After Surgery
for Breast Cancer
This trial studies how well paclitaxel, trastuzumab, and pertuzumab work in eliminating further chemotherapy after surgery in patients with HER2-positive stage II-IIIa breast cancer who have no cancer remaining at surgery (either in the breast or underarm lymph nodes) after pre-operative chemotherapy and HER2-targeted therapy. Drugs used in chemotherapy, such as paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Trastuzumab and pertuzumab are both a form of "targeted therapy" because they work by attaching themselves to specific molecules (receptors) on the surface of tumor cells, known as HER2 receptors. When these drugs attach to HER2 receptors, the signals that tell the cells to grow are blocked and the tumor cell may be marked for destruction by the body's immune system. Giving paclitaxel, trastuzumab, and pertuzumab may enable fewer chemotherapy drugs to be given without compromising patient outcomes compared to the usual treatment.
Recruiting1 award Phase 227 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Cleveland Clinic Cancer Center Independence?
Cleveland Clinic Cancer Center Independence is a medical facility located in Independence, Ohio. This center is recognized for care of Breast Cancer, Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Prostate Cancer and other specialties. Cleveland Clinic Cancer Center Independence is involved with conducting 141 clinical trials across 186 conditions. There are 15 research doctors associated with this hospital, such as Nathan A. Pennell, Aaron Gerds, MD, MS, Joel N. Saltzman, and Gregory M. M. Videtic.